Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Finished Goods: 2024

Historic Finished Goods for Syndax Pharmaceuticals (SNDX) over the last 1 years, with Dec 2024 value amounting to $36,000.

  • Syndax Pharmaceuticals' Finished Goods was N/A to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $36,000 for FY2024, which is N/A change from last year.
  • Per Syndax Pharmaceuticals' latest filing, its Finished Goods stood at $36,000 for FY2024.
  • In the past 5 years, Syndax Pharmaceuticals' Finished Goods ranged from a high of $36,000 in FY2024 and a low of $36,000 during FY2024.
  • Over the past 1 years, Syndax Pharmaceuticals' median Finished Goods value was $36,000 (recorded in 2024), while the average stood at $36,000.